The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Salvage therapy after failure from anti-PD-1 single agent treatment: A Study by the German ADOReg melanoma registry.
 
Michael Weichenthal
Honoraria - Bristol-Myers Squibb; Medac; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; Sanofi; Sun Pharma; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Johnson & Johnson (Inst); Merck Sharp & Dohme (Inst); Millennium (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Amgen; Merck Sharp & Dohme; Novartis; Pierre Fabre
 
Selma Ugurel
Honoraria - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Roche
Research Funding - Bristol-Myers Squibb (Inst); Merck Serono (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
 
Ulrike M. Leiter
Honoraria - MSD Oncology; Novartis; Roche Pharma AG
Consulting or Advisory Role - MSD Oncology; Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - Roche Pharma AG
 
Imke Satzger
Honoraria - Bristol-Myers Squibb; Novartis; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Roche Pharma AG; Sanofi/Regeneron
Research Funding - Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Katharina C. Kähler
Honoraria - Amgen; Bristol-Myers Squibb; MSD Oncology; Novartis; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Roche Pharma AG
Research Funding - Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology; Novartis; Roche Pharma AG
 
Julia Welzel
Honoraria - Almirall; Leo Pharma
Consulting or Advisory Role - Almirall Hermal GmbH; DermaLumics (Inst); Michelson Diagnostics (Inst)
Research Funding - Almirall Hermal GmbH (Inst); Leo Pharma (Inst)
 
Claudia Pföhler
Honoraria - Abbvie; Bristol-Myers Squibb; Celgene; Leo Pharma; Merck Serono; MSD Oncology; Novartis; Roche Pharma AG
 
Ingrid Feldmann-Böddeker
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis
 
Friedegund Elke Meier
Honoraria - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche; Sanofi
Research Funding - Novartis
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche; Sanofi
 
Patrick Terheyden
Honoraria - Biofrontera; Bristol-Myers Squibb; CureVac; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Merck KGaA; Novartis; Pierre Fabre; Roche; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pierre Fabre
 
Sebastian Haferkamp
Honoraria - Amgen; Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - AMGEN; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
 
Rudolf Herbst
Employment - Helios Kliniken
 
Jens Ulrich
Consulting or Advisory Role - Roche
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - NOVARTIS (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Medac
 
Jochen Utikal
Honoraria - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche
Research Funding - Apogenix (Inst); Elsalys Biotech (Inst); Noxxon Pharma (Inst); TILT Biotherapeutics (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche
 
Alexander Kreuter
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis
 
Ralf Gutzmer
Honoraria - Almirall; Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Novartis; Pierre Fabre; Roche Pharma AG; Sanofi/Regeneron; Sun Pharma
Consulting or Advisory Role - 4SC; Almirall; Amgen; Bristol-Myers Squibb; Leo Pharma; MSD Oncology; Novartis; Pierre Fabre; Roche/Genentech; Sun Pharma; Takeda
Research Funding - Amgen (Inst); Johnson & Johnson (Inst); Novartis (Inst); Pfizer (Inst)
 
Dirk Schadendorf
Honoraria - 4SC; Agenus; Amgen; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Grunenthal; Immunocore; Incyte; LEO Pharma; Merck Serono; Merck Sharp & Dohme; Mologen; Novartis; Pfizer; Philogen; Pierre Fabre; Regeneron; Roche/Genentech; Sysmex
Consulting or Advisory Role - 4SC; Amgen; Bristol-Myers Squibb; Immunocore; Incyte; Merck Serono; Merck Sharp & Dohme; Mologen; Novartis; Pierre Fabre; Roche/Genentech; Sanofi/Regeneron
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Incyte; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; Merck Serono; Novartis; Roche/Genentech
 
Peter Mohr
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche/Genentech; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche